Skip to main content
. 2023 Aug 3;12:e79548. doi: 10.7554/eLife.79548

Table 1. Most recent bisphosphonate claim among all users.

Drug (route) N %
Alendronate / alendronic acid (oral) 340,810 75.4%
Etidronate (oral) 14 0.0%
Ibandronate / ibandronic acid (oral) 37,988 8.4%
Ibandronic acid (injection/infusion) 1169 0.3%
Pamidronate (injection/infusion) 1121 0.2%
Risedronate (oral) 18,991 4.2%
Zoledronic acid (injection/infusion) 51,958 11.5%